Shree Renuka Sugars Limited
NSE: RENUKAMarket Closed • NSE
Day range
52 week range
Shree Renuka Sugars Limited closed at INR21.72 (+0.42%) on volume 0.56x its 20-day average, trading 29.53% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved -108.3% QoQ
2019-09-23
AGM Announced
Annual General Meeting
2018-09-18
AGM Announced
Annual General Meeting
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Established operational history in the sector
Active institutional participation
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Confectioners.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| — | Annual General Meeting | Annual General Meeting | — | 23 Sept 2019 |
| — | Annual General Meeting | Annual General Meeting | — | 18 Sept 2018 |
| — | Annual General Meeting | Annual General Meeting | — | 12 Dec 2017 |
| — | Annual General Meeting | Annual General Meeting | — | 16 Sept 2016 |
| — | Annual General Meeting | Annual General Meeting | — | 21 Sept 2015 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Hindustan Unilever LimitedHINDUNILVR Open analysis | ₹4.36L | 41.63 | 2.39% | ₹17,341.00 | ₹2,680.00 | +10.05% | -3.18% |
 ITC LimitedITC Open analysis | ₹3.33L | 16.79 | 6.27% | ₹19,114.00 | ₹4,509.00 | -11.08% | -15.61% |
 Nestlé India LimitedNESTLEIND Open analysis | ₹2.57L | 67.43 | 0.91% | ₹6,378.00 | ₹959.00 | +25.16% | +48.22% |
 Avenue Supermarts LimitedDMART Open analysis | ₹2.29L | 74.97 | 0.00% | ₹18,795.00 | ₹860.00 | +14.88% | +11.25% |
 Varun Beverages LimitedVBL Open analysis | ₹1.49L | 44.10 | 0.46% | ₹8,451.00 | ₹1,525.00 | +20.44% | +15.09% |
 Britannia Industries LimitedBRITANNIA Open analysis | ₹1.16L | 44.63 | 1.91% | ₹5,000.00 | ₹593.00 | +8.18% | +14.04% |
 Marico LimitedMARICO Open analysis | ₹1.02L | 53.99 | 0.51% | ₹3,957.00 | ₹652.00 | +22.85% | +27.10% |
 UNITED SPIRITS LIMITEDUNITDSPR Open analysis | ₹96,993.57 | 57.52 | 1.29% | ₹3,054.00 | ₹539.00 | +3.67% | +28.03% |
Shree Renuka Sugars Ltd is a Wilmar- controlled integrated sugar and bioenergy company engaged in sugar milling and refining, ethanol, cogeneration, sugar trading and engineering. It operates mills across Karnataka, Maharashtra and Uttar Pradesh and port-based refineries at Kandla and Haldia.[1][2]
IndiaConsumer Defensive
Is Shree Renuka Sugars Limited Shariah compliant?
Shree Renuka Sugars Limited is currently screened as Non-Compliant (Financial Ratios) under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (155.19%) exceeds AAOIFI threshold (≤ 33%).
What is Shree Renuka Sugars Limited's current valuation relative to peers?
Shree Renuka Sugars Limited trades at a P/E of N/A compared to the sector median of 21.4x, and a Price-to-Book of -1.7x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of zero debt. Interest coverage is -0.1x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at -4.1% while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.